Skip to main content
Equibles

Atom Investors LP

Position in SGMT — Sagimet Biosciences Inc.

CIK 1738902 AUSTIN, TX
Back to SGMT Full portfolio

Position in SGMT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,674,719
+$2,519,325 QoQ
Shares Held
346,018
+1596.7% QoQ
Ownership
0.557%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#31
of 122 holders
Holding Since
Jun 2025
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SGMT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Atom Investors LP holds $106,011,536 across 52 Biotechnology names. SGMT ranks #16 (2.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RYTM
Rhythm Pharmaceuticals, Inc.
 73,465 $8,156,818
2 IMNM
Immunome Inc.
 297,489 $6,303,791
3 RARE
Ultragenyx Pharmaceutical Inc.
 171,771 $5,735,433
4 DNTH
Dianthus Therapeutics, Inc. /DE/
 37,228 $3,628,985
5 CELC
Celcuity Inc.
 34,488 $3,608,134
6 SNDX
Syndax Pharmaceuticals Inc
 162,524 $3,552,774
7 AXSM
Axsome Therapeutics, Inc.
 14,179 $3,470,593
8 JAZZ
Jazz Pharmaceuticals plc
 13,474 $3,246,829

All Filings in SGMT

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,674,719 346,018
2025-06-30 $155,394 20,393